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2003.—Measuring insulin sensitivity during the physiological milieu
of oral glucose perturbation, e.g., a meal or an oral glucose tolerance
test, would be extremely valuable but difficult since the rate of
appearance of absorbed glucose is unknown. The reference method is
a tracer two-step one: first, the rate of appearance of glucose (Ra mealref )
is reconstructed by employing the tracer-to-tracee ratio clamp tech-
nique with two tracers and a model of non-steady-state glucose
kinetics; next, this Ra mealref is used as the known input of a model
describing insulin action on glucose kinetics to estimate insulin
sensitivity (SIref). Recently, a nontracer method based on the oral
minimal model (OMM) has been proposed to estimate simultaneously
the above quantities, denoted Ra meal and SI, respectively, from plasma
glucose and insulin concentrations measured after an oral glucose
perturbation. This last method has obvious advantages over the tracer
method, but its domain of validity has never been assessed against a
reference method. It is thus important to establish whether or not the
“nontracer” Ra meal and SI compare well with the “tracer” Ra mealref and SIref
. We do this comparison on a database of 88 subjects, and it is very
satisfactory: Ra meal profiles agree well with the Ra mealref and correlation of
SIref with SI is r 0.86 (P 0.0001). We conclude that OMM candidates
as a reliable tool to measure both the rate of glucose absorption and
insulin sensitivity from oral glucose tests without employing tracers.
glucose kinetics; rate of appearance of glucose; tracer; meal; insulin
resistance
INSULIN SENSITIVITY (SI), i.e., the ability of insulin to enhance
glucose utilization and inhibit glucose production, is an impor-
tant parameter to assess the efficiency of the glucose regulatory
system. This index, useful not only for diagnosis but also for
assessing the efficacy of a given therapy, is usually measured
using methods involving an intravenous administration of
glucose and/or insulin, such as the glucose clamp technique
(10) or the intravenous glucose tolerance test (IVGTT) inter-
preted with the minimal model (5). However, both of these
techniques realize experimentally a “nonphysiological milieu”
since neither the elevated insulin-basal glucose condition of the
clamp technique nor the rapid glucose and insulin perturbations
of an IVGTT reflect the condition of daily living. Therefore, it
is highly desirable to have a method able to quantify insulin
sensitivity in a normal life “physiological milieu,” e.g., during
a meal.
Unfortunately, the estimation of insulin sensitivity after an
oral glucose perturbation is not an easy task, the major obstacle
being that the rate of appearance of glucose absorption is
unknown. The most reliable, probably the reference method for
estimating insulin sensitivity during a meal, is a two-step
procedure. First, the rate of appearance of absorbed glucose is
reconstructed as accurately as possible with a tracer method. A
reliable method uses a tracer-to-tracee clamp technique in
conjunction with a model of glucose kinetics in nonsteady state
(14). Two tracers are necessary, one given intravenously, mim-
icking the rate of appearance of glucose absorption, and one
together with the meal. Once the rate of appearance of absorbed
glucose is known, to estimate insulin sensitivity one has to explain
the meal plasma glucose measurements with a model describing
insulin action on glucose production and disposal. This model
already exists and is the classic single-compartment minimal
model. In fact, when glucose and insulin change smoothly as
during an oral test, the single-compartment description of glucose
kinetics has proven to be sufficiently accurate (2).
In summary, the state-of-the-art method for the estimation of
insulin sensitivity during an oral test entails the use of a
two-tracer protocol in conjunction with a model of non-steady-
state glucose kinetics to obtain the rate of appearance of
glucose absorption (Ra mealref ), and then the use of the minimal
model to extract insulin sensitivity (SIref) from plasma glucose
and insulin concentrations. Since this is an expensive and
labor-intensive procedure, an alternative approach capable of
reducing the cost and the effort is required to favor a wide-
spread application of the oral test for the estimation of insulin
sensitivity. Recently, a nontracer method based on a new
model, the oral minimal model (OMM), has been proposed to
estimate insulin sensitivity (SI) together with the glucose rate
of appearance (Ra meal) from plasma glucose and insulin con-
centrations measured after a meal or an oral glucose tolerance
test (OGTT; see Ref. 9). The method has obvious advantages
over the reference tracer method discussed above, but its
performance in recovering both insulin sensitivity and rate of
appearance of glucose absorption has never been compared
with other methods, albeit some reassuring indirect validation
results are available: in two studies (3, 9) insulin sensitivity
was compared with that obtained from IVGTT performed in
the same subjects, and correlation was satisfactory. It is thus
important to establish whether or not the “nontracer” Ra meal
and SI provided by OMM compare well with the “tracer”
Ra mealref and SIref provided by the reference method.
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This is precisely the aim of the present contribution. We do
this comparison on a database consisting of 88 subjects who
underwent the triple-tracer meal protocol described (4).
DATABASE AND PROTOCOL
The database consists of 88 normal subjects (46 males and
42 females; age  58  2 yr, body weight  77  2 kg) who
received a triple-tracer mixed meal (10 kcal/kg, 45% carbohy-
drate, 15% protein, and 40% fat) containing 1  0.02 g/kg
glucose. The meal was labeled with [13C]glucose (in the
following tracer I) to segregate the exogenous, i.e., coming
from the meal, glucose (Gex) from the endogenous one (Gend).
Two additional tracers {[6,6-2H2]glucose (tracer II) and
[6-3H]glucose, (tracer III)} were infused intravenously at vari-
able rates, mimicking the endogenous glucose production
(EGP) and Ra meal, respectively; by this way, the change in the
plasma tracer-to-tracee ratios tracer II/Gend and tracer III/Gex
was minimized, and Steele equation provided an essentially
model-independent estimate of EGP and Ra meal (4). As far as
the present contribution is concerned, one only needs two of
the three tracers, i.e., the one labeling the meal (tracer I) and
the one mimicking Ra meal (tracer III).
Plasma samples were collected at times (t) 120, 30,
20, 10, 0, 5, 10, 15, 20, 30, 40, 50, 60, 75, 90, 120, 150,
180, 210, 240, 260, 280, 300, 360, and 420 min. Figure 1




Reconstruction of Ra mealref . An accurate estimation of Ra mealref was
obtained by applying the single-compartment model of Steele et al.











where F(t) is the pump infusion profile of tracer III, V is the
distribution volume of glucose, p is the pool fraction, and Gex is the
concentration in plasma of the oral ingested glucose.
Estimation of SIref . By knowing Ra mealref , it was possible to identify
the classic minimal model in each subject by using Ra mealref as the
known exogenous input. The model is described by




X˙ t  p2ref  Xt p3ref  [It Ib]; X0 0
(2)
where G is plasma glucose concentration, I is plasma insulin concen-
tration, suffix “b” denotes basal values, X is insulin action, V is the
distribution volume, and SG, p2, and p3 are model parameters (super-
script “ref” stands for “reference”). Specifically, SG is the fractional
(i.e., per unit distribution volume) glucose effectiveness measuring
glucose ability, per se, to promote glucose disposal and inhibit glucose
production; p2 is the rate constant describing the dynamics of insulin
action; p3 is the parameter governing the magnitude of insulin action.




 Vref dl kg1  min1  	U1  ml (3)
Nontracer Method
A new model has been recently developed to estimate insulin
sensitivity together with the glucose rate of appearance during an oral
test (9). It couples the single-compartment minimal model with a
parametric description of the glucose rate of appearance:
G˙ t  SG Xt  Gt SG  Gb Ra mealtV ; G0 GbX˙ t  p2  Xt p3  [It Ib]; X0 0
(4)
The parametric description of Ra meal proposed (9) is a piecewise-





i1ti ti1  t ti1 per ti1 t ti i 1...8
0 otherwise
(5)




 V (dl kg1  min1  	U1  ml) (6)
Parameter Estimation
Tracer method. To estimate Ra mealref , we used the single-compart-
ment model of Steele et al. (14). Because the tracer-to-tracee ratio was
well clamped, a two-compartment model gave virtually the same
results (4). The tracer-to-tracee ratio profile was smoothed using
WINSTODEC (13), which also provides the first derivative of the
Fig. 1. Concentration of plasma glucose and insulin during a meal in normal
subjects (mean, n  88).
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smoothed signal. Finally, the minimal model of glucose kinetics was
numerically identified by nonlinear least squares (7, 8), as imple-
mented in SAAM II (Simulation Analysis and Modeling software; see
Ref. 1). Measurement error on glucose data was assumed to be
independent, Gaussian, with zero mean and known SD [coefficient of
variation (CV)  2%]. Insulin concentration is the model-forcing
function and was assumed to be known without error. The model
provided estimates of SGref , Vref, p2ref, and SIref . Knowledge of Ra mealref
allowed us to calculate fref [the fraction of the ingested dose (D) that








Nontracer method. OMM was numerically identified with the same
strategy described above. However, OMM identification requires a
number of assumptions that were discussed in detail (9). Briefly, to
ensure its a priori identifiability, one has to assume values for V and
SG. Here, we fixed them to the median obtained with the tracer
method, i.e., V  Vm-ref, SG  SGm-ref (median was preferred to mean
values since parameters are not normally distributed, see RESULTS). To
improve numerical identifiability of the remaining parameters, p2, p3,
and 
i (i  1 . . . 8), a Gaussian bayesian prior was considered on the
square root of p2ref (SQRp2ref), which is normally distributed (see
RESULTS): SQRp2  mean SQRp2ref; SD  10%. Finally, a constraint
was imposed to guarantee that the area under the estimated Ra meal
equals the total amount of ingested glucose, D, multiplied by the
fraction of the ingested dose that is actually absorbed, f (fixed to the
median of reference values f  fm-ref): this constraint provides an
additional relationship among the unknown parameters 
i, thus re-
ducing the number of unknowns by one. In summary, OMM provides
estimates of SI, p2, and 
i (i.e., the Ra meal profile).
Statistical Analysis
Data are presented as means  SE. Two-sample comparisons were
done by Wilcoxon signed-rank test, and Shapiro-Wilk test was used to
verify if parameters are normally distributed (significance level set to
5%). Pearson’s correlation was used to evaluate univariate correlation.
To investigate how sensitive the OMM estimate of SI was to the
assumptions on V, SG, f, and p2, we investigated the relationship
between the percent deviation of SI, SI%, and the percent deviation
of the various parameters that were fixed (namely V%, SG%, f%,
and p2%) using regression analysis. The percent deviation of each
parameter was calculated as the difference between the reference and
OMM parameter value divided by the reference. We used single-
regression analysis to determine the association of SI% with V%,
SG%, f%, and p2% separately. Next, we used forward and
backward stepwise multiple regression (using F ratio-to-remove  4
and F ratio-to-enter  3.996) to assess the relevance of the fixed
parameters as predictors of the error affecting SI.
RESULTS
Tracer Method
Ra mealref obtained using the tracer-to-tracee ratio clamp tech-
nique is shown in Fig. 2A.
The fit of the minimal model (Eq. 2) was satisfactory, since,
as indicated in Fig. 3A, average weighted residuals did not
show systematic deviations from zero. Reference parameters of
glucose kinetics were estimated with good precision: SGref 
0.031  0.002 min1 (CV  12  1%; mean  SE); Vref 
1.50  0.05 dl/kg (CV  4  1%); p2ref  0.013  0.001
min1 (CV  11  1%); SIref  11.55  0.68  104
dl kg1 min1 	U1 ml (CV  5  1%). The fraction of
ingested glucose that reaches plasma, calculated as the ratio
between the area under Ra mealref and the ingested dose, was
f ref  0.89  0.02. Because the kinetic parameters were not
normally distributed (P  0.01 by Shapiro-Wilk test; Fig. 4),
median values were different from the mean ones: SGm-ref 
0.025 min1; Vm-ref  1.45 dl/kg; p2m-ref  0.012 min1;
SIm-ref  10.35  104 dl kg1 min1 	U1 ml; fm-ref  0.9.
As anticipated in Parameter Estimation, SQRp2ref was normally
distributed (P  0.35 by Shapiro-Wilk test), whereas p2ref was
not (SQRp2ref  0.11  0.004 min1/2).
Nontracer Method
The mean profile of Ra meal provided by the model is shown
in Fig. 2A. The fit of OMM was satisfactory (Fig. 3B). Insulin
sensitivity was estimated with good precision: SI  11.68 
0.73  104 dl kg1 min1 	U1 ml, CV  7  0.3%;
parameters 
i were also estimated with good precision, the less
precise parameter being 
8, which is expected to be very close
to zero: 
1  5.36  0.33 mg kg1 min1 (CV  12  2%),

2  7.78  0.24 mg kg1 min1 (CV  10  0.4%), 
3 
6.00  0.28 mg kg1 min1 (CV  27  9%), 
4  5.05 
0.22 mg kg1 min1 (CV  11  0.5%), 
5  4.77  0.28
mg kg1 min1 (CV  30  15%), 
6  3.52  0.19
mg kg1 min1 (CV  12  2%), 
7  2.09  0.09 mg 
Fig. 2. A: comparison between the time course of the rate of meal absorption
(Ra meal) predicted by the oral minimal model (OMM) and the reference Ra
(Ra mealref ) reconstructed with the tracer method (mean, n  88). t, Time. B:
deviation of OMM Rmeal from Rmealref , Rmeal  (Rmealref  Rmeal)/Rmealref (vertical
bars represent SD).
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kg1 min1 (CV  6  0.5%), and 
8  0.34  0.05
mg kg1 min1 (CV  42  4%). The bayesian estimate of
p2 gives p2  0.011  0.0005 min1 (CV  15  0.7%).
Comparison
A good agreement was found between the OMM Ra meal and
Ra mealref profiles (mean curves are shown in Fig. 2A). We
calculated the relative deviation of OMM Ra meal estimates
from the reference Ra mealref in each breakpoint of the piecewise-
linear function as:
Ra meal
Ra mealref  Ra meal
Ra mealref
(8)
The temporal profile of the mean Ra meal is shown in Fig.
2B and does not present systematic deviation from zero.
Moreover, SI provided by OMM and SIref were not significantly
different (SI  11.68  0.73 104 dl kg1 min1 	U1 ml,
SIref  11.55  0.68  104 dl kg1 min1 	U1 ml) and
well correlated (r  0.86, P  0.0001; Fig. 5). To quantify the
agreement between OMM and reference SI in each individual,






It was found that  SI   29  3% on average (range
0.42–160%). Finally, to assess the influence of model param-
eters SG, f, p2, and V on individual SI estimates, a multivariate
regression was performed of SI vs. SG, f, p2, and V
covariates. Results indicate that SG, f, and p2 contribute to
SI variance (r  0.752, P  0.0001), whereas V does not.
We conclude that the OMM is quite robust and most applicable
in population studies, but it is less accurate in estimating the
individual values of SI.
DISCUSSION
Insulin sensitivity measures the ability of insulin to inhibit
glucose production and enhance glucose utilization. It is used
in clinical and epidemiological studies to quantify insulin
resistance as a risk factor for pathological conditions, such as
obesity and hypertension, and to assess the efficacy of a given
therapy. Insulin sensitivity is usually estimated using intrave-
nous administration of glucose and/or insulin, such as the
glucose clamp technique (10) or the IVGTT interpreted with
the minimal model (5). However, both of these techniques
measure insulin sensitivity by experimentally creating a non-
physiological milieu, and it would be important to be able to
measure this parameter in a normal-life physiological milieu,
e.g., during a meal.
Recently, a new OMM has been proposed that is able to
estimate insulin sensitivity SI in a given individual from
plasma glucose and insulin concentration measured after an
oral glucose perturbation, by simultaneously reconstructing
also the rate of appearance of absorbed glucose (Ra meal). In this
study, we have validated the OMM against what can be
considered today the state-of-art reference method for estimat-
ing insulin sensitivity during a meal or an OGTT. The refer-
ence method relies on tracers and comprises the following two
steps: first, a two-tracer protocol is used in conjunction with a
model of non-steady-state glucose kinetics to obtain the rate of
glucose absorption; second, the calculated rate of glucose
absorption is used in conjunction with the classic minimal
model to measure insulin sensitivity from the measured plasma
glucose and insulin concentrations.
To test the nontracer OMM against the tracer method, we
analyzed with both methods 88 subjects who underwent the
triple-tracer meal protocol described (4). The comparison be-
tween the Ra meal profile obtained with the OMM and Ra mealref
indicates a good agreement between the two (Fig. 2). The
temporal plot of the deviations of OMM Ra meal estimates from
the reference in each breakpoint of the piecewise-linear func-
tion does not present systematic deviation from zero. However,
some differences between the reference profile and OMM
prediction can be seen at the individual level. A likely expla-
nation for these discrepancies is that OMM requires us to fix
some parameters. In particular, the use of a population value
for the fraction of absorbed dose (f) forces the area under the
curve of Ra meal to take on a value that is correct on average but
differs slightly at the individual level. The comparison between
insulin sensitivity indexes obtained by OMM and the reference
model indicates an excellent agreement in average between the
estimates of insulin sensitivity (SIref  11.55  1  104
dl kg1 min1 	U1 ml, SI  11.68  2  104 dl kg1 
Fig. 3. Weighted residuals (wres; vertical bars represent SD) of the minimal
model of glucose kinetics forced with the tracer method Ra mealref (A) and of the
nontracer OMM, which reconstructs Ra meal (B).
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min1 	U1 ml); correlation between the two indexes is sat-
isfactory (r  0.86, P  0.0001; Fig. 5).
The ability of the OMM to provide results that are in good
agreement with those provided by the more complex and
expensive tracer method hinge on a simple but effective para-
metric modeling of the rate of glucose absorption and on the
assumption that some model parameters such as V, SG, and f
equal their population values. In addition, the model uses a
bayesian prior on p2 to improve the numerical identification
properties of the model. The novelty of the present study is that
the reference model provides values of kinetic parameters
during a meal. The large number of subjects studied in the
present experiments permitted the distributions to be deter-
mined for all parameters. As is evident in Fig. 4, kinetic
parameters were not normally distributed (as confirmed by the
Shapiro-Wilk normality test, P  0.01). Therefore, the median
rather than mean values (Vm-ref  1.45 dl/kg, SGm-ref  0.025
min1, fm-ref  0.90) were used as reference for OMM to
better describe nonnormality of the distributions. SAAM II
software can only provide Gaussian priors for the Bayesian
estimation. Because SQRp2, but not p2, is normally distributed
(P  0.35 and P  0.0001, respectively, by Shapiro-Wilk test),
Fig. 4. Distributions of reference model pa-
rameter estimates (SQRp2 denotes square
root of p2) obtained from the tracer method.
SGref, reference glucose effectiveness; Vref,
reference distribution volume; SIref, refer-
ence sensitivity index; p2ref, reference rate
constant of insulin action; fref, reference frac-
tion of ingested glucose that is absorbed.
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the model was parameterized to make SQRp2 explicit and use
the Gaussian prior on it (Fig. 4). With the use of these reference
values, OMM provided an accurate estimate of insulin sensi-
tivity not significantly different from SIref (SI  11.68  0.73
vs. SIref  11.55  0.68  104 dl kg1 min1 	U1 ml)
also when insulin sensitivity is expressed per unit of distribu-
tion volume (SI  8.05  0.50 vs. SIref  8.56  0.60  104
min 	U1 ml). In previous studies (3, 9), mean population
values derived from IVGTT and clamp studies were used [V 
1.7 dl/kg; SG  0.014 min1, p2  0.03 min1, f  0.86 (4)].
As seen above, mean values of parameters during a meal are
different from those of the IVGTT; in particular, volume of
distribution and p2 are lower (Vref  1.50 dl/kg, p2ref  0.013
min1), whereas glucose effectiveness is higher (SGref  0.031
min1). However, the OMM method is quite robust on aver-
age: if intravenous values of kinetic parameters are used for
OMM identification, insulin sensitivity (SIiv  11.82 
0.66  104 dl kg1 min1  	U1  ml; see Ref. 3) is not
statistically different from SIref (insulin sensitivity per unit of
distribution volume is different, SIiv  6.95  0.39  104
min 	U1  ml vs. SIref  8.56  0.60  104 min 
	U1  ml, P  0.0005 because of differences in the distri-
bution volume) and correlation between OMM and the
reference model remains very good (r  0.83, P  0.001).
The necessity of using some population a priori knowledge
for OMM numerical identification can affect SI estimates in the
single individual: the absolute percentage deviation between
reference and OMM measurements is  SI   29  3% on
average (range 0.42–160%). The discrepancy between the
estimates of insulin sensitivity obtained with the reference
model and with the OMM arises, at least in part, from the
assumptions that parameters such as V, SG, f, and p2 take on
the same value in all subjetcs (p2 is constrained to a bayesian
prior). To investigate how sensitive the OMM estimate of SI
was to the assumptions made on V, SG, f, and p2, we investi-
gated the relationship existing between the percent deviation of
SI, SI%, and the percent deviation on the various parameters
that were fixed (namely V%, SG%, f%, and p2%) using
multiple-regression analysis. We found that the percentage
deviation of f, SG, and p2 from the fixed values explains the
deviation in SI estimate (0.752, P  0.0001), whereas the
deviation of V does not give a significant contribution to the
regression. We conclude that the OMM is quite robust and well
applicable in population studies, although it is less accurate in
estimating the individual values of SI.
Until now, it has been possible to compare the SI provided
by OMM with the analogous index obtained from the IVGTT
(3, 9). Although SI values estimated during IVGTT were 40%
lower than OMM ones, they correlated well with each other
(r  0.62, P  0.001). Whereas these results were reassuring,
one source of concern was that the experimental conditions
during the IVGTT were markedly different from those during
the oral test both in terms of the route of glucose administration
and in the pattern of change of plasma glucose and insulin
concentrations. Also, in the previous study (3, 9), the IVGTT
studies and the oral tests were not performed on the same days,
adding a potential source of variability to the comparison. Thus
the present validation of the OMM estimates of Ra meal and SI
against an independent “oral reference technique” adds credi-
bility to the OMM and provides the necessary prerequisite for
a more general validation of this novel method against the
hyperinsulinemic-euglycemic clamp: this important issue may
be addressed in a separate study, but the available preliminary
results (6) are reassuring.
Finally, it is also of interest to compare OMM and reference
SI with other indexes, such as the Homeostasis Model Assess-
ment (HOMA) (15), the Quantitative Insulin Sensitivity Check
Index (QUICKI) (11), and the insulin sensitivity index (ISI) of
Matsuda-De Fronzo (12), frequently used to measure insulin
sensitivity during an OGTT or meal. Correlation between
SIOMM and ISI index is r  0.63, whereas correlation with
HOMA or QUICKI is much lower (r  0.43 and 0.46,
respectively). This was expected because HOMA and QUICKI
indexes are derived from glucose and insulin concentration in
the basal state, whereas OMM and ISI indexes are both
estimated using the 420-min data. Similar results were found if
SIref was compared with the three indexes (HOMA: r  0.43;
QUICKI: r  0.44; ISI: r  0.59).
In conclusion, we have validated the nontracer OMM
method by comparing its Ra meal and SI measurements with
Fig. 5. A: comparison between SI estimated
from the OMM and SIref. B: correlation plot.
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those obtained by the tracer reference method. Our results
indicate that the OMM provides an accurate estimation of both
the Ra meal profile and insulin sensitivity. Thus the OMM
candidates as a simple, cost-effective, and reliable tool to
measure both the rate of glucose absorption and insulin sensi-
tivity from oral glucose tests without employing tracers.
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